Page 85 - Avian Virology: Current Research and Future Trends

78 | Samal
Lindh, E., Ek-Kommonen, C., Väänänen, V.M., Alasaari, J., Vaheri, A., McGinnes, L.W., and Morrison, T.G. (1995). The role of individual
Vapalahti, O., and Huovilainen, A. (2012). Molecular epidemiology of oligosaccharide chains in the activities of the HN glycoprotein of
outbreak-associated and wild-waterfowl-derived Newcastle disease virus Newcastle disease virus. Virology 212, 398–410.
strains in Finland, including a novel class I genotype. J. Clin. Microbiol. McGinnes, L.W., Wilde, A., and Morrison, T.G. (1987). Nucleotide
50, 3664–3673. https://doi.org/10.1128/JCM.01427-12 sequence of the gene encoding the Newcastle disease virus
Liu, H., Albina, E., Gil, P., Minet, C., and de Almeida, R.S. (2017a). hemagglutinin-neuraminidase protein and comparisons of
Two-plasmid system to increase the rescue efficiency of paramyxoviruses paramyxovirus hemagglutinin-neuraminidase protein sequences. Virus
by reverse genetics: The example of rescuing Newcastle disease virus. Res. 7, 187–202.
Virology 509, 42–51. McGinnes, L.W., Reitter, J.N., Gravel, K., and Morrison, T.G. (2003).
Liu, H., de Almeida, R.S., Gil, P., and Albina, E. (2017b). Comparison of the Evidence for mixed membrane topology of the Newcastle disease virus
efficiency of different Newcastle disease virus reverse genetics systems. J. fusion protein. J. Virol. 77, 1951–1963.
Virol. Methods 249, 111–116. McLellan, J.S., Chen, M., Leung, S., Graepel, K.W., Du, X., Yang, Y., Zhou, T.,
Liu, Y.L., Hu, S.L., Zhang, Y.M., Sun, S.J., Romer-Oberdorfer, A., Baxa, U., Yasuda, E., Beaumont, T., et al. (2013). Structure of RSV fusion
Veits, J., Wu, Y.T., Wan, H.Q., and Liu, X.F. (2007). Generation of a glycoprotein trimer bound to a prefusion-specific neutralizing antibody.
velogenic Newcastle disease virus from cDNA and expression of the Science 340, 1113–1117. https://doi.org/10.1126/science.1234914
green fluorescent protein. Arch. Virol. 152, 1241–1249. https://doi. Mebatsion, T., Verstegen, S., De Vaan, L.T., Römer-Oberdörfer, A., and
org/10.1007/s00705-007-0961-x Schrier, C.C. (2001). A recombinant Newcastle disease virus with
Loke, C.F., Omar, A.R., Raha, A.R., and Yusoff, K. (2005). Improved low-level V protein expression is immunogenic and lacks pathogenicity
protection from velogenic Newcastle disease virus challenge following for chicken embryos. J. Virol. 75, 420–428. https://doi.org/10.1128/
multiple immunizations with plasmid DNA encoding for F and HN JVI.75.1.420-428.2001
genes. Vet. Immunol. Immunopathol. 106, 259–267. Melanson, V.R., and Iorio, R.M. (2004). Amino acid substitutions in the
Longhi, S., Bloyet, L.M., Gianni, S., and Gerlier, D. (2017). How order and F-specific domain in the stalk of the newcastle disease virus HN protein
disorder within paramyxoviral nucleoproteins and phosphoproteins modulate fusion and interfere with its interaction with the F protein. J.
orchestrate the molecular interplay of transcription and replication. Virol. 78, 13053–13061.
Cell. Mol. Life Sci. 74, 3091–3118. https://doi.org/10.1007/ Meng, C., Qiu, X., Yu, S., Li, C., Sun, Y., Chen, Z., Liu, K., Zhang, X., Tan, L.,
s00018-017-2556-3 Song, C., et al. (2016). Evolution of Newcastle disease virus quasispecies
Luque, L.E., and Russell, C.J. (2007). Spring-loaded heptad repeat residues diversity and enhanced virulence after passage through chicken air sacs. J.
regulate the expression and activation of paramyxovirus fusion protein. Virol. 90, 2052–2063. https://doi.org/10.1128/JVI.01801-15
J. Virol. 81, 3130–3141. Meulemans, G., Letellier, C., Gonze, M., Carlier, M.C., and Burny, A. (1988).
Macpherson, L.W. (1956). Some observations on the epizootiology of Newcastle disease virus F glycoprotein expressed from a recombinant
Newcastle disease. Can. J. Comp. Med. Vet. Sci. 20, 155–168. vaccinia virus vector protects chickens against live-virus challenge. Avian
Mahon, P.J., Mirza, A.M., and Iorio, R.M. (2011). Role of the two sialic acid Pathol. 17, 821–827.
binding sites on the Newcastle disease virus HN protein in triggering the Mia Kim, L., Suarez, D.L., and Afonso, C.L. (2008). Detection of a broad
interaction with the F protein required for the promotion of fusion. J. range of class I and II Newcastle disease viruses using a multiplex
Virol. 85, 12079–12082. https://doi.org/10.1128/JVI.05679-11 real-time reverse transcription polymerase chain reaction assay. J. Vet.
Maminiaina, O.F., Gil, P., Briand, F.X., Albina, E., Keita, D., Andriamanivo, Diagn. Invest. 20, 414–425.
H.R., Chevalier, V., Lancelot, R., Martinez, D., Rakotondravao, R., Miller, P.J., King, D.J., Afonso, C.L., and Suarez, D.L. (2007). Antigenic
et al. (2010). Newcastle disease virus in Madagascar: identification differences among Newcastle disease virus strains of different genotypes
of an original genotype possibly deriving from a died out ancestor of used in vaccine formulation affect viral shedding after a virulent
genotype IV. PLOS ONE 5, e13987. https://doi.org/10.1371/journal. challenge. Vaccine 25, 7238–7246.
pone.0013987 Miller, P.J., Kim, L.M., Ip, H.S., and Afonso, C.L. (2009). Evolutionary
Manoharan, V.K., Khattar, S.K., Paldurai, A., Kim, S.H., and Samal, S.K. dynamics of Newcastle disease virus. Virology 391, 64–72. https://doi.
(2016). A Y527A mutation in the fusion protein of Newcastle disease org/10.1016/j.virol.2009.05.033
virus strain LaSota leads to a hyperfusogenic virus with increased Miller, P.J., Decanini, E.L., and Afonso, C.L. (2010). Newcastle disease:
replication and immunogenicity. J. Gen. Virol. 97, 287–292. https://doi. evolution of genotypes and the related diagnostic challenges. Infect.
org/10.1099/jgv.0.000350 Genet. Evol. 10, 26–35. https://doi.org/10.1016/j.meegid.2009.09.012
Manoharan, V.K., Varghese, B.P., Paldurai, A., and Samal, S.K. (2018). Effect Mirza, A.M., and Iorio, R.M. (2013). A mutation in the stalk of the
of fusion protein cleavage site sequence on generation of a genotype VII Newcastle disease virus hemagglutinin-neuraminidase (HN) protein
Newcastle disease virus vaccine. PLOS ONE 13, e0197253. https://doi. prevents triggering of the F protein despite allowing efficient HN-F
org/10.1371/journal.pone.0197253 complex formation. J. Virol. 87, 8813–8815. https://doi.org/10.1128/
Marcos, F., Ferreira, L., Cros, J., Park, M.S., Nakaya, T., García-Sastre, A., and JVI.01066-13
Villar, E. (2005). Mapping of the RNA promoter of Newcastle disease Mirza, A.M., Sheehan, J.P., Hardy, L.W., Glickman, R.L., and Iorio, R.M.
virus. Virology 331, 396–406. (1993). Structure and function of a membrane anchor-less form of the
Marino, O.C., and Hanson, R.P. (1987). Cellular and humoral response of hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus. J.
in ovo-bursectomized chickens to experimental challenge with velogenic Biol. Chem. 268, 21425–21431.
Newcastle disease virus. Avian Dis. 31, 293–301. Morgan, R.W., Gelb, J., Pope, C.R., and Sondermeijer, P.J. (1993). Efficacy in
Martinez-Sobrido, L., Gitiban, N., Fernandez-Sesma, A., Cros, J., Mertz, chickens of a herpesvirus of turkeys recombinant vaccine containing the
S.E., Jewell, N.A., Hammond, S., Flano, E., Durbin, R.K., García-Sastre, fusion gene of Newcastle disease virus: onset of protection and effect of
A., et al. (2006). Protection against respiratory syncytial virus by a maternal antibodies. Avian Dis. 37, 1032–1040.
recombinant Newcastle disease virus vector. J. Virol. 80, 1130–1139. Morrison, T., Hinshaw, V.S., Sheerar, M., Cooley, A.J., Brown, D.,
Mase, M., Imai, K., Sanada, Y., Sanada, N., Yuasa, N., Imada, T., Tsukamoto, McQuain, C., and McGinnes, L. (1990). Retroviral expressed
K., and Yamaguchi, S. (2002). Phylogenetic analysis of Newcastle disease hemagglutinin-neuraminidase protein protects chickens from Newcastle
virus genotypes isolated in Japan. J. Clin. Microbiol. 40, 3826–3830. disease virus induced disease. Microb. Pathog. 9, 387–396.
Mast, J., and Demeestere, L. (2009). Electron tomography of negatively Morrison, T., McQuain, C., and McGinnes, L. (1991). Complementation
stained complex viruses: application in their diagnosis. Diagn. Pathol. 4, between avirulent Newcastle disease virus and a fusion protein gene
5. https://doi.org/10.1186/1746-1596-4-5 expressed from a retrovirus vector: requirements for membrane fusion.
McGinnes, L.W., and Morrison, T.G. (1994). The role of the individual J. Virol. 65, 813–822.
cysteine residues in the formation of the mature, antigenic HN protein Morrison, T.G. (2003). Structure and function of a paramyxovirus fusion
of Newcastle disease virus. Virology 200, 470–483. protein. Biochim. Biophys. Acta 1614, 73–84.
Moura, V.M., Susta, L., Cardenas-Garcia, S., Stanton, J.B., Miller, P.J.,
Afonso, C.L., and Brown, C.C. (2016). Neuropathogenic capacity